Canadian COVID-19 Genomics Network
The Canadian COVID-19 Genomics Network, or CanCOGeN, is a country-wide, cross-agency network for large-scale SARS-CoV-2 and human host sequencing to track viral origin, spread and evolution, characterize the role of human genetics in COVID-19 disease.1)
CanCOGeN is a “consortium of Canadian federal, provincial and regional public health authorities and their healthcare partners, academia, industry, hospitals, research institutes and large-scale sequencing centres”, launched by Genome Canada in April 2020.
Affiliations
Partners
The official membership of the CanCOGeN network is composed of Genome Canada and its subsidiaries, hospital labs, partner organizations, public health labs, and university labs.2)
Genome Canada network
Hospital Labs
- Sunnybrook Health Sciences Centre/Shared Hospital Laboratory
Partner Organizations
Provincial Public Health Labs
- BC Centre for Disease Control (BCCDC)
- Alberta Precision Labs (APL)
- Public Health Ontario (PHO)
University Labs
External links
1)
CanCOGeN. Genome Canada. Retrieved February 9, 2022, from https://archive.ph/LpFH3
2)
CanCOGeN Partners. Genome Canada. Retrieved February 9, 2022, from https://archive.ph/KcLqD
